In addition, several pathophysiological mechanisms in MASLD likely contribute to this maladaptive trajectory, including disrupted liver acute-phase responses, mitochondrial dysfunction, neutrophil dysfunction and sustained NF-κB activation in hepatic and myeloid cells [35]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.